M O Vannozzi - JoVE Visualize

Showing results (1-10 of 23) with videos related to

Pageof 3

Sort By:

Chemotherapy|April 26, 2006

Docetaxel pharmacokinetics with pre- and post-dialysis administration in a hemodyalized patientM Mencoboni, R Olivieri, M O Vannozzi, et al.

Journal of Cancer Research and Clinical Oncology|January 1, 1997

Suramin/epidoxorubicin association in hormone-refractory prostate cancer: preliminary results of a pilot phase II studyL Miglietta, L Canobbio, C Granetto, et al.

European Journal of Cancer (Oxford, England : 1990)|December 1, 1996

Cisplatin combined with the new cisplatin-procaine complex DPR: in vitro and in vivo studiesM Viale, M O Vannozzi, F Merlo, et al.

Anti-Cancer Drugs|July 11, 1998

Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell linesM Viale, I Pastrone, C Pellecchia, et al.

Anticancer Research|June 6, 1998

Hydration regimen and hematological toxicity of a cisplatin-based chemotherapy regimen. Clinical observations and pharmacokinetic analysisG Numico, M Benasso, M O Vannozzi, et al.

Toxicology and Applied Pharmacology|October 1, 1996

Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis-diamminedichloroplatinum(II)M Esposito, M Viale, M O Vannozzi, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003

Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patientsG Lunardi, M O Vannozzi, C Bighin, et al.

The Journal of Thoracic and Cardiovascular Surgery|March 30, 1999

Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: a feasibility and pharmacokinetic studyG B Ratto, D Civalleri, M Esposito, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002

Influence of alternate sequences of epirubicin and docetaxel on the pharmacokinetic behaviour of both drugs in advanced breast cancerG Lunardi, M Venturini, M O Vannozzi, et al.

Il Giornale Di Chirurgia|April 1, 1997

[Effects of adjuvant hyaluronidase in tumors refractory to chemotherapy. Review of the literature and pharmacokinetics of cisplatin after regional administration in animals and humans]D Civalleri, M Esposito, F De Cian, et al.

Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:

Pageof 3

Chemotherapy|April 26, 2006

Docetaxel pharmacokinetics with pre- and post-dialysis administration in a hemodyalized patientM Mencoboni, R Olivieri, M O Vannozzi, et al.

Journal of Cancer Research and Clinical Oncology|January 1, 1997

Suramin/epidoxorubicin association in hormone-refractory prostate cancer: preliminary results of a pilot phase II studyL Miglietta, L Canobbio, C Granetto, et al.

European Journal of Cancer (Oxford, England : 1990)|December 1, 1996

Cisplatin combined with the new cisplatin-procaine complex DPR: in vitro and in vivo studiesM Viale, M O Vannozzi, F Merlo, et al.

Anti-Cancer Drugs|July 11, 1998

Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell linesM Viale, I Pastrone, C Pellecchia, et al.

Anticancer Research|June 6, 1998

Hydration regimen and hematological toxicity of a cisplatin-based chemotherapy regimen. Clinical observations and pharmacokinetic analysisG Numico, M Benasso, M O Vannozzi, et al.

Toxicology and Applied Pharmacology|October 1, 1996

Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis-diamminedichloroplatinum(II)M Esposito, M Viale, M O Vannozzi, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003

Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patientsG Lunardi, M O Vannozzi, C Bighin, et al.

The Journal of Thoracic and Cardiovascular Surgery|March 30, 1999

Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: a feasibility and pharmacokinetic studyG B Ratto, D Civalleri, M Esposito, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002

Influence of alternate sequences of epirubicin and docetaxel on the pharmacokinetic behaviour of both drugs in advanced breast cancerG Lunardi, M Venturini, M O Vannozzi, et al.

Il Giornale Di Chirurgia|April 1, 1997

[Effects of adjuvant hyaluronidase in tumors refractory to chemotherapy. Review of the literature and pharmacokinetics of cisplatin after regional administration in animals and humans]D Civalleri, M Esposito, F De Cian, et al.

Pageof 3